Metastatic breast cancer is a disease with a high mortality rate. Taxanes, a specific class of chemotherapeutic agents including Taxol(r) and Taxotere(r) have been demonstrated to be effective in tumor control and symptom relief in metastatic breast cancer patients. However, it was unclear whether there is a benefit in survival compared to non-taxane compounds. This study evaluated the effect of taxanes within the clinical setting during patients' individual courses of sequential treatments. Metastatic breast cancer patients were recruited from one practice of the University of Pittsburgh...